BioMelbourne News

Speaking Opportunities: Devices + Diagnostics Lab March 2018 – Disruptive Diagnostics

We’re starting to work on the Program for the 2018 Devices + Diagnostics Lab which will take place on Tuesday 27th March next year. If you have any suggestions for speakers, topics or technologies that you would like…

Ask Industry Anything (Again) – Tuesday 28th November 2017

BioMelbourne Network – Bringing industry and academia together! In November 2016, we launched “Ask Industry Anything” a new event which gave tables of students and researchers from leading academic organisations the opportunity to ask leaders from the biotechnology,…

BioMelbourne Network has appointed Lusia Guthrie to the BioMelbourne Network’s Board of Directors as of September 2017

With over 35 years in pharmaceutical and bioscience industries, Lusia Guthrie is an experienced executive and medtech entrepreneur, with strong leadership skills and international industry networks. She started her career as a Medical Laboratory Scientist before joining the…

BioMelbourne Network Welcomes Revisions to Skilled Migration Visas

Revisions to the skilled migration list have been welcomed by many BioMelbourne Network members across the biotechnology, medical technology and pharmaceutical sector. The restoration of occupations such as life scientist, biotechnologist, CEO/General Manager, and biochemist to the Medium…

2017 Connecting Women – Charity Announced!

The BioMelbourne Network Connecting Women Lunch is now fully booked with over 400 women set to attend on Friday 2nd June. We’re also delighted that we have received a record number of nominations for the BioMelbourne Network Women in Leadership…

Joint statement on the Research & Development Tax Incentive 18 April 2017

Don’t rip the guts out of Australian medical research commercialisation Commercialisation of Australian medical research is under serious threat if the package of measures put by the ‘Ferris, Finkel, Fraser’ Review of the Research & Development (R&D) Tax…

September 2016 – Changes to the R&D Tax Incentive: Putting a handbrake on innovation

The R&D Tax Incentive Review paper was released on 28th of September, making recommendations on changes to the scheme – including a proposed $2Million cap on the annual cash refund payable under the R&D Tax Incentive. The proposed…

Tribute to Athina Tsagarakis

The BioMelbourne Network team were saddened to hear of the passing of past staff member, Athina Tsagarakis,  last week at the age of 49 years.  Our condolences to Athina’s family and friends during this difficult time. Members of…

MyGolgi – Winners of the Innovation Showcase Scholarship

Melbourne-based health technology start-up company, MyGolgi, have won the 2016 Victorian State Government supported Innovation Showcase Scholarship. MyGolgi offer an easy-to-use wearable that provides consumers with continuous feedback for injury rehabilitation and prevention. The innovative device consists of…

Andrew Maxwell joins BioMelbourne Network Board

The BioMelbourne network is delighted to be able to announce that Andrew Maxwell is joining our Board of Directors as of this month. As the Managing Director of Chatsworth Associates, Andrew has worked with innovators, entrepreneurs and established…

Medtech Trade Mission Going Ahead – Limited Places Still Available!

BioMelbourne Network, on behalf of the State Government of Victoria, is leading a major Medtech Mission to the United States including AdvaMed 2016 – the largest annual medical technology conference on the US calendar. There are still limited…

BioMelbourne Network Members Invited to Meet with International Medtronic Diabetes Representative

US based Medtronic representative, Dr Huzefa Neemuchwala, will be in Melbourne this month.  BioMelbourne Network member organisations are invited to meet with Dr Neemuchwala. Interested organisations, please contact Dr Krystal Evans on 9667 6161 Dr Huzefa Neemuchwala, PhD MBA,…

Home

News & opinion

Member Directory

Events